The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Sees Significant Growth in Short Interest

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the target of a large growth in short interest in February. As of February 28th, there was short interest totalling 13,500 shares, a growth of 17.4% from the February 13th total of 11,500 shares. Based on an average trading volume of 30,900 shares, the days-to-cover ratio is currently 0.4 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock Performance

Shares of CGABL remained flat at $17.88 during midday trading on Wednesday. The stock had a trading volume of 13,441 shares, compared to its average volume of 24,689. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 12-month low of $17.48 and a 12-month high of $20.85. The company’s 50-day moving average is $18.12 and its two-hundred day moving average is $18.93.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Saturday, February 15th. Shareholders of record on Saturday, February 1st were paid a dividend of $0.2891 per share. This is a positive change from Carlyle Group Inc. 4.625% Subordinated Notes due 2061’s previous quarterly dividend of $0.29. The ex-dividend date of this dividend was Friday, January 31st. This represents a $1.16 dividend on an annualized basis and a yield of 6.47%.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.